E/e' ratio is a strong prognostic predictor of mortality in patients with non-valvular atrial fibrillation with preserved left ventricular systolic function.
The purpose of this study was to investigate the prognostic values of the E/e' ratio and other echocardiographic and clinical parameters in patients with non-valvular atrial fibrillation (AF) with preserved left ventricular (LV) systolic function. A total of 488 patients (322 men, age: 66 ± 11 years) with non-valvular AF with preserved LV systolic function (LV ejection fraction >50%) were included. The E and e' velocities were measured in 5 consecutive heart beats and averaged. Mean follow-up duration after enrollment was 17.7 ± 5.3 months. All-cause deaths occurred in 45 patients (cardiovascular deaths: n=29). There were significant differences in age (65.6 ± 11.3 vs. 71.5 ± 9.1, P < 0.001) and hemoglobin concentration (13.6 ± 2.9 vs. 11.5 ± 3.4g/dl, P<0.0001) between the deceased group and the survivors. E/e' ratio in the deceased group was significantly higher than that in the survivors (17.67 ± 3.39 vs. 10.8 ± 3.30, P < 0.001). Survival analysis showed that a high E/e' ratio (> 15.0) represents a poorer prognosis (P < 0.001 by Log-Rank test) than an E/e' ratio of 15 and below. Multivariate analysis identified 2 significant variables that were predictive of all-cause deaths: hemoglobin (hazard ratio (HR)=0.806, 95% confidence interval (CI) = 0.733-0.886, P < 0.0001), and E/e' > 15 (HR=3.064, 95%CI = 1.38-6.804, P = 0.006). E/e' ratio is a useful independent prognostic parameter for predicting mortality in patients with AF with preserved LV systolic function.